Oxygène Médicinal Liquide Sol (Oxygen)

Oxygen, the active ingredient in Oxygène Médicinal Liquide Sol, is a medical gas presented as a liquid for inhalation use. It is employed to increase oxygen levels in patients with respiratory insufficiency, particularly in acute care and emergency settings. GNH USA supplies Oxygène Médicinal Liquide Sol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Oxygène Médicinal Liquide Sol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Oxygène Médicinal Liquide Sol provides supplemental oxygen therapy for conditions where tissue oxygenation is compromised.

- Acute hypoxemia: restores adequate arterial oxygen saturation in emergency and intensive care patients. - Chronic obstructive pulmonary disease (COPD) exacerbations: supports breathing during acute flare‑ups. - Post‑operative recovery: maintains oxygenation after surgery to reduce hypoxic complications. - Carbon‑carbon dioxide retention syndrome (hyper‑capnic respiratory failure): assists ventilation by providing high‑flow oxygen. - High‑altitude exposure: prevents hypoxia in individuals ascending to high elevations.

Oxygen therapy is generally well tolerated, but adverse reactions can occur, especially when delivered at high concentrations or for prolonged periods.

Common Side Effects: - Dry or irritated nasal passages: discomfort or soreness in the nasal mucosa. - Headache: mild to moderate headache associated with high flow rates. - Cough: irritation of the airway leading to a cough reflex. - Fatigue: transient tiredness after initiation of therapy.

Serious or Rare Side Effects: - Oxygen toxicity: pulmonary inflammation or seizures at very high concentrations. - Fire hazard: increased risk of combustion in oxygen‑rich environments. - Barotrauma: lung injury from excessive pressure during mechanical ventilation. - Retinopathy of prematurity: ocular damage in preterm infants receiving high‑flow oxygen. - Hypercapnia: CO₂ retention in patients with chronic respiratory disease when oxygen flow is excessive.

When using Oxygène Médicinal Liquide Sol, clinicians should assess patient suitability and monitor for adverse events.

- Assess patient respiratory status: evaluate baseline oxygen saturation and ventilation needs. - Adjust flow rate carefully: titrate to maintain target SpO₂ while avoiding hyperoxia. - Monitor for fire risk: keep away from open flames and smoking materials. - Use compatible delivery devices: ensure tubing and masks are rated for medical‑grade oxygen. - Store at ambient temperature: keep container below 25°C, protect from direct sunlight and moisture.

Oxygen can influence the efficacy and safety of several concurrent therapies. Proper assessment and monitoring are essential.

Major Interactions (Avoid): - Nitric oxide therapy: excess oxygen can reduce nitric oxide effectiveness and increase oxidative stress. - Para‑aminosalicylic acid: high oxygen concentrations may enhance oxidative toxicity.

Moderate Interactions (Monitor Closely): - Sedatives and anesthetics: supplemental oxygen may potentiate respiratory depression. - Chemotherapy agents (e.g., cyclophosphamide): oxygen may increase oxidative damage to healthy tissues. - Antioxidant supplements: high oxygen levels can counteract antioxidant effects, requiring dose adjustments.